Shared Decision Making, Perceived Control Improves Patient Satisfaction During Radiation Therapy
April 23rd 2014Cancer patients felt more satisfied with their radiation treatment when they remained active in treatment decisions, according to a study conducted by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Ramucirumab Approved for Advanced Stomach Cancer
April 22nd 2014The FDA has approved ramucirumab (Cyramza) as a single-agent treatment for patients with unresectable or metastatic gastric cancer or gastroesophageal junction (GEJ) adenocarcinoma following fluoropyrimidine- or platinum-containing therapy.
Study Reinforces Need to Monitor Childhood Cancer Survivors
April 21st 2014Adult survivors of childhood cancer face significant health problems as they age and are five times more likely than their siblings to develop new cancers, heart, and other serious health conditions beyond the age of 35 years
CMS to Reimburse Concurrent Hospice and Curative Care
April 15th 2014The Centers for Medicare & Medicaid Services (CMS) is piloting a new Medicare Choices Care Model, designed to provide a new option for Medicare beneficiaries to concurrently receive palliative care services from hospice providers while also receiving services from curative care providers.
ASCO Rolls Out First Three Guidelines on Survivorship Care
April 14th 2014The American Society of Clinical Oncology (ASCO) announced today three new evidence-based clinical practice guidelines on neuropathy, fatigue, and depression and anxiety in cancer survivors, the first three in a planned series of ASCO guidelines on survivorship care.
Study Links High BMI Before Diagnosis to Increased Death Risk in Colorectal Cancer
April 10th 2014Patients who had a high Body Mass Index (BMI) before being diagnosed with colorectal cancer had an increased risk of death after diagnosis, even if their tumor harbored the microsatellite instability (MSI) marker
Updated Findings Show Palbociclib Improves PFS, not OS
April 7th 2014Palbociclib, an inhibitor of cyclin-dependent kinases (CDK) 4 and 6, more than doubled progression-free survival (PFS) when used in combination with letrozole for patients with estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer
New Study Shows Fertility Drugs Do Not Increase Breast Cancer Risk, Monitoring Still Warranted
April 3rd 2014Women who took the fertility drugs clomiphene citrate (Clomid) or gonadotropins did not experience an increased risk for breast cancer compared with women who were not treated with those medications, according to a 30-year follow-up study published in the April issue of Cancer Epidemiology, Biomarkers & Prevention.
Phone Application Helps Endometrial and Breast Cancer Survivors Lose Weight
March 28th 2014Early-stage overweight endometrial and breast cancer survivors had moderate success in lowering their body mass index (BMI) and waste circumference after using the web and smart phone/tablet–based weight loss application "Lose It!"
25% of Breast Cancer Survivors Report Financial Burdens After Treatment
March 26th 2014A new study has found that one in four breast cancer survivors report that they are worse off financially even 4 years after their last treatment and 12% report they still have medical debt from their treatment.